Sl. Stancheva et Lg. Alova, BIOGENIC MONOAMINE UPTAKE BY RAT-BRAIN SYNAPTOSOMES DURING AGING - EFFECTS OF NOOTROPIC DRUGS, General pharmacology, 25(5), 1994, pp. 981-987
1. In experiments on young (3-5-month-old), adult (10-11-month-old) an
d old (21-22-month-old) rats, it was found that significant age-relate
d changes occurred in the high-affinity uptake of dopamine (DA), norad
renaline (NA) and serotonin (5-HT) by cortical and striatal synaptosom
es. 2. Changes in DA, NA and 5-HT uptake during aging are suggested to
be neurochemical correlates of cognition and memory deficits that dev
elops in senescence.3. The in vitro effects of the nootropic drugs pir
acetam, aniracetam, meclofenoxate and adafenoxate on the DA, NA and 5-
HT uptake by cortical and striatal synaptosomes from young rats were s
tudied. Administered in increasing concentrations (1 x 10(-4) to 5 x 1
0(-3) M) these drugs inhibited monoamine uptake. 4. Adafenoxate proved
to be a more potent monoamine uptake inhibitor than the other three d
rugs; it inhibited the uptake in the frontal cortex and striatum witho
ut selectivity for either monoaminergic system. It is suggested that a
dafenoxate affects cognition through the involvement of central neurot
ransmission and particularly through the inhibition of monoamine uptak
e systems.